Antifungal drug resistance in Aspergillus

[11] BROUGHTON MC, 1991, MYCOSES, V34, P75, DOI 10.1111/j.1439-0507.1991.tb00623.x

[12] CHEN CCH, 1974, NATURE, V251, P656

[13] DISTRIBUTION AND ACTIVITY OF AMPHOTERICIN-B IN HUMANS [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (05) : 1037 - 1043

[14] In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (05) : 509 - 512

[15] THE ACTION OF AMPHOTERICIN-B ON THE STEROL COMPOSITION OF KLUYVEROMYCES-BULGARICUS AND KLUYVEROMYCES-LACTIS [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1986, 32 (09) : 738 - 742

[16] Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) : 531 - 533

[17] In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (12) : 1087 - 1093

[18] In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (04) : 553 - 555

[19] Fungal transporters involved in efflux of natural toxic compounds and fungicides [J]. FUNGAL GENETICS AND BIOLOGY, 2000, 30 (01) : 1 - 15

[20] Multidrug resistance in Aspergillus nidulans involves novel ATP-binding cassette transporters [J]. Molecular and General Genetics MGG, 1997, 254 (4): : 417 - 426

[11] BROUGHTON MC, 1991, MYCOSES, V34, P75, DOI 10.1111/j.1439-0507.1991.tb00623.x

[12] CHEN CCH, 1974, NATURE, V251, P656

[13] DISTRIBUTION AND ACTIVITY OF AMPHOTERICIN-B IN HUMANS [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (05) : 1037 - 1043

[14] In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1997, 29 (05) : 509 - 512

[15] THE ACTION OF AMPHOTERICIN-B ON THE STEROL COMPOSITION OF KLUYVEROMYCES-BULGARICUS AND KLUYVEROMYCES-LACTIS [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1986, 32 (09) : 738 - 742

[16] Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) : 531 - 533

[17] In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (12) : 1087 - 1093

[18] In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (04) : 553 - 555

[19] Fungal transporters involved in efflux of natural toxic compounds and fungicides [J]. FUNGAL GENETICS AND BIOLOGY, 2000, 30 (01) : 1 - 15

[20] Multidrug resistance in Aspergillus nidulans involves novel ATP-binding cassette transporters [J]. Molecular and General Genetics MGG, 1997, 254 (4): : 417 - 426